1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Carcinoma, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gebhard, MM; Herfarth, C; Klar, E; Maksan, SM; Ryschich, E; Schmidt, J; Werner, J | 1 |
| Benveniste, J; Besson, P; Bougnoux, P; Fetissoff, F; Lansac, J; Lanson, M; Pitton, C | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Reduced basal and stimulated leukocyte adherence in tumor endothelium of experimental pancreatic cancer.
Topics: Animals; Blood Flow Velocity; Blood Vessels; Carcinoma; Cell Adhesion; Chemotactic Factors; Endothelium; Endothelium, Vascular; Erythrocytes; Leukocytes; Lymphocyte Culture Test, Mixed; N-Formylmethionine Leucyl-Phenylalanine; Pancreatic Neoplasms; Platelet Activating Factor; Rats; Venules | 1999 |
Presence of PAF-acether in human breast carcinoma: relation to axillary lymph node metastasis.
Topics: Axilla; Breast; Breast Neoplasms; Carcinoma; Humans; Lymph Nodes; Lymphatic Metastasis; Platelet Activating Factor; Tissue Distribution | 1989 |